TABLE 2.
Cox proportional hazards regression model analysis for OS of ESCC patients.
| Characteristics | Total (N) | Univariate analysis |
Multivariate analysis | ||
| Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | ||
| T stage | 79 | ||||
| T1&T2 | 35 | Reference | |||
| T3&T4 | 44 | 0.942 (0.414–2.142) | 0.887 | ||
| N stage | 78 | ||||
| N0 | 46 | Reference | |||
| N1 | 26 | 1.960 (0.789–4.869) | 0.147 | 1.315 (0.353–4.896) | 0.684 |
| N2&N3 | 6 | 4.310 (1.301–14.279) | 0.017 | 7.977 (1.200–53.005) | 0.032 |
| M stage | 73 | ||||
| M0 | 70 | Reference | |||
| M1 | 3 | 3.197 (0.909–11.238) | 0.070 | 4.643 (0.878–24.553) | 0.071 |
| APOC1 | 82 | ||||
| Low | 41 | Reference | |||
| High | 41 | 2.302 (1.027–5.158) | 0.043 | 3.210 (1.119–9.208) | 0.030 |
| Gender | 82 | ||||
| Female | 12 | Reference | |||
| Male | 70 | 10.030 (1.323–76.071) | 0.026 | 191838562.424 (0.000–Inf) | 0.998 |
| Pathologic stage | 79 | ||||
| Stage I&Stage II | 54 | Reference | |||
| Stage IV&Stage III | 25 | 2.178 (0.958–4.952) | 0.063 | 0.512 (0.123–2.133) | 0.358 |
| Age | 82 | ||||
| <=60 | 53 | Reference | |||
| >60 | 29 | 1.592 (0.676–3.749) | 0.288 | ||